Edit
PolyCore Therapeutics LLC
http://www.polycoretherapeutics.com/Last activity: 02.11.2022
Active
Developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders
Employees: 11-50
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
| 02.11.2022 | Xontogeny | xontogeny.... |
Mentions in press and media 6
| Date | Title | Description |
| 06.06.2022 | JVS Philadelphia Fund for Women Invests and Provides Grants of $650K to 12 Philadelphia Women Led Regional Businesses | “The talent and potential for women founded businesses in our region is exceptional, and I am thrilled with the level of interest in this fund,” said Judith M. von Seldeneck, founder of Diversified Search Group. “Ben Franklin’s commitment t... |
| 12.04.2022 | PolyCore Therapeutics Secures Seed Financing to Address Motor Symptoms and Dyskinesia Associated with Parkinson’s Disease | “Nearly 60,000 new cases of Parkinson’s Disease are diagnosed in the United States each year, and the current gold standard for motor symptom management results in dyskinesias for nearly 50% of patients who are treated for more than four ye... |
| 18.10.2021 | Ben Franklin Approved $2.1M in 12 Early Stage Companies | |
| 17.05.2021 | PolyCore Therapeutics Awarded Supplemental NINDS Grant to Understand the Effects of its Lead Compound, PCT-3012, to Treat Cognitive Impairment in Alzheimer’s disease | of the National Institutes of Health (NIH) to fund research of its lead compound, PCT-3012, in the treatment of cognitive impairment in Alzheimer’s disease. More than 6 million Americans of all ages are living with Alzheimer’s, with one in ... |
| 28.07.2017 | Twelve Health Companies Creating an Impact in our Region | When you talk about trends in tech there are two mentions that you cannot leave out: impact and health technology. Philadelphia has blossomed into a burgeoning hub for startups in health technology. With pillars in the industry like Siemens... |
| 18.08.2016 | Ben Franklin Approved $2.9M for 13 Early Stage Companies |